Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Inventory Average: 2011-2024

Historic Inventory Average for Anika Therapeutics (ANIK) over the last 14 years, with Dec 2024 value amounting to $24.1 million.

  • Anika Therapeutics' Inventory Average fell 63.55% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 63.55%. This contributed to the annual value of $24.1 million for FY2024, which is 24.86% down from last year.
  • Latest data reveals that Anika Therapeutics reported Inventory Average of $24.1 million as of FY2024, which was down 24.86% from $32.1 million recorded in FY2023.
  • Anika Therapeutics' Inventory Average's 5-year high stood at $41.1 million during FY2021, with a 5-year trough of $24.1 million in FY2024.
  • For the 3-year period, Anika Therapeutics' Inventory Average averaged around $31.4 million, with its median value being $32.1 million (2023).
  • As far as peak fluctuations go, Anika Therapeutics' Inventory Average surged by 57.53% in 2020, and later decreased by 24.86% in 2024.
  • Yearly analysis of 5 years shows Anika Therapeutics' Inventory Average stood at $34.1 million in 2020, then rose by 20.55% to $41.1 million in 2021, then dropped by 7.84% to $37.9 million in 2022, then fell by 15.28% to $32.1 million in 2023, then fell by 24.86% to $24.1 million in 2024.